{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:11:50Z","timestamp":1791475910643,"version":"4.3.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S00016X\/1"],"award-info":[{"award-number":["MR\/S00016X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["200517\/Z\/16\/Z"],"award-info":[{"award-number":["200517\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014976","name":"Liverpool School of Tropical Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014976","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204806\/Z\/16\/Z"],"award-info":[{"award-number":["204806\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["NIF\\R1\\192161"],"award-info":[{"award-number":["NIF\\R1\\192161"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.tips.2021.02.005","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T09:36:28Z","timestamp":1616578588000},"page":"340-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Small Molecule Drug Discovery for Neglected Tropical Snakebite"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3945-0530","authenticated-orcid":false,"given":"Rachel H.","family":"Clare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5314-4970","authenticated-orcid":false,"given":"Steven R.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4070-3256","authenticated-orcid":false,"given":"Rohit N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8035-4719","authenticated-orcid":false,"given":"Nicholas R.","family":"Casewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2021.02.005_bb0005","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(09)60233-6","article-title":"Rescuing the bottom billion through control of neglected tropical diseases","volume":"373","author":"Hotez","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.02.005_bb0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7861\/clinmedicine.19-2-157","article-title":"Neglected tropical diseases: elimination and eradication","volume":"19","author":"Bodimeade","year":"2019","journal-title":"Clin. Med. (Lond)"},{"key":"10.1016\/j.tips.2021.02.005_bb0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-018-0327-4","article-title":"Challenges and recent progress in drug discovery for tropical diseases","volume":"559","author":"De Rycker","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.02.005_bb0020","first-page":"239","article-title":"The London Declaration on Neglected Tropical Diseases: 5 years on","volume":"375","author":"Molyneux","year":"2017","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.tips.2021.02.005_bb0025","doi-asserted-by":"crossref","first-page":"17063","DOI":"10.1038\/nrdp.2017.63","article-title":"Snakebite envenoming","volume":"3","author":"Guti\u00e9rrez","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tips.2021.02.005_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050218","article-title":"The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths","volume":"5","author":"Kasturiratne","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.tips.2021.02.005_bb0035","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(18)31224-8","article-title":"Vulnerability to snakebite envenoming: a global mapping of hotspots","volume":"392","author":"Longbottom","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.02.005_bb0040","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1371\/journal.pntd.0000569","article-title":"Snake envenoming: a disease of poverty","volume":"3","author":"Harrison","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0045","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/trstmh\/try134","article-title":"The time is now: a call for action to translate recent momentum on tackling tropical snakebite into sustained benefit for victims","volume":"113","author":"Harrison","year":"2019","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.tips.2021.02.005_bb0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1371\/journal.pntd.0007059","article-title":"Strategy for a globally coordinated response to a priority neglected tropical disease: snakebite envenoming","volume":"13","author":"Williams","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0055","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/S0140-6736(19)31232-2","article-title":"Snakebite \u2013 emerging from the shadows of neglect","volume":"393","author":"The Lancet","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.02.005_bb0060","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2020.05.006","article-title":"Causes and consequences of snake venom variation","volume":"41","author":"Casewell","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2021.02.005_bb0065","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0070","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/bjh.14591","article-title":"Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise","volume":"177","author":"Slagboom","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tips.2021.02.005_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fevo.2019.00218","article-title":"Multifunctional toxins in snake venoms and therapeutic implications: from pain to hemorrhage and necrosis","volume":"7","author":"Ferraz","year":"2019","journal-title":"Front. Ecol. Evol."},{"key":"10.1016\/j.tips.2021.02.005_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/toxins8040093","article-title":"Hemorrhage caused by snake venom metalloproteinases: a journey of discovery and understanding","volume":"8","author":"Guti\u00e9rrez","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002302","article-title":"Neurotoxicity in snakebite \u2013 the limits of our knowledge","volume":"7","author":"Ranawaka","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0090","series-title":"Skin Necrosis","first-page":"109","article-title":"Skin necrosis due to snakebites","author":"Fujioka","year":"2015"},{"key":"10.1016\/j.tips.2021.02.005_bb0095","series-title":"Snake Venoms","first-page":"327","article-title":"Cytotoxic effects of snake venoms","author":"Chakrabarty","year":"2017"},{"key":"10.1016\/j.tips.2021.02.005_bb0100","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/bcp.12739","article-title":"Adverse reactions to snake antivenom, and their prevention and treatment","volume":"81","author":"de Silva","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2021.02.005_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1081\/CLT-120021113","article-title":"Snake antivenoms","volume":"41","author":"Lalloo","year":"2003","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.tips.2021.02.005_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005969","article-title":"Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa","volume":"11","author":"Harrison","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001670","article-title":"Consequences of neglect: analysis of the sub-Saharan African snake antivenom market and the global context","volume":"6","author":"Brown","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005361","article-title":"Recombinant snakebite antivenoms: a cost-competitive solution to a neglected tropical disease?","volume":"11","author":"Laustsen","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0125","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/17460441.2019.1646723","article-title":"How can monoclonal antibodies be harnessed against neglected tropical diseases and other infectious diseases?","volume":"14","author":"Laustsen","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.tips.2021.02.005_bb0130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/toxins8090248","article-title":"Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation","volume":"8","author":"Lewin","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/molecules23020391","article-title":"Exploration of the inhibitory potential of varespladib for snakebite envenomation","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.tips.2021.02.005_bb0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/toxins12050309","article-title":"Repurposing cancer drugs batimastat and marimastat to inhibit the activity of a group I metalloprotease from the venom of the western diamondback rattlesnake, Crotalus atrox","volume":"12","author":"Layfield","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8314","article-title":"Preclinical validation of a repurposed metal chelator as a community-based therapeutic for hemotoxic snakebite","volume":"12","author":"Albulescu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2021.02.005_bb0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/biomedicines8090297","article-title":"Neutralizing effects of small molecule inhibitors and metal chelators on coagulopathic Viperinae snake venom toxins","volume":"8","author":"Xie","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.tips.2021.02.005_bb0155","doi-asserted-by":"crossref","first-page":"4320175","DOI":"10.1155\/2018\/4320175","article-title":"Developing small molecule therapeutics for the initial and adjunctive treatment of snakebite","volume":"2018","author":"Bulfone","year":"2018","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.tips.2021.02.005_bb0160","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1038\/s41467-020-19981-6","article-title":"A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite","volume":"11","author":"Albulescu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2021.02.005_bb0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(09)61159-4","article-title":"The Global Snake Bite Initiative: an antidote for snake bite","volume":"375","author":"Williams","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.02.005_bb0170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/toxins11060363","article-title":"The urgent need to develop novel strategies for the diagnosis and treatment of snakebites","volume":"11","author":"Williams","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0175","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1567201816666190201143457","article-title":"Topical and transdermal drug delivery: from simple potions to smart technologies","volume":"16","author":"Benson","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.tips.2021.02.005_bb0180","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jama.2013.282836","article-title":"Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial","volume":"311","author":"Nicholls","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.tips.2021.02.005_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2018.11.292","article-title":"Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2","volume":"157","author":"Bryan-Quir\u00f3s","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.tips.2021.02.005_bb0190","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/toxins10110479","article-title":"Delayed LY333013 (oral) and LY315920 (intravenous) reverse severe neurotoxicity and rescue juvenile pigs from lethal doses of Micrurus fulvius (eastern coral snake) venom","volume":"10","author":"Lewin","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0195","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/toxins10100380","article-title":"Delayed oral LY333013 rescues mice from highly neurotoxic, lethal doses of Papuan taipan (Oxyuranus scutellatus) venom","volume":"10","author":"Lewin","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/toxins12020131","article-title":"Varespladib (LY315920) and methyl varespladib (LY333013) abrogate or delay lethality induced by presynaptically acting neurotoxic snake venoms","volume":"12","author":"Guti\u00e9rrez","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0205","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3390\/toxins10120516","article-title":"Coagulotoxic cobras: clinical implications of strong anticoagulant actions of African spitting Naja venoms that are not neutralised by antivenom but are by LY315920 (varespladib)","volume":"10","author":"Bittenbinder","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0210","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","article-title":"Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes","volume":"17","author":"Winer","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tips.2021.02.005_bb0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2148-7-63","article-title":"The evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio rerio","volume":"7","author":"Huxley-Jones","year":"2007","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.tips.2021.02.005_bb0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2017.04.001","article-title":"Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom","volume":"132","author":"Arias","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.tips.2021.02.005_bb0225","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4269\/ajtmh.2000.63.313","article-title":"Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA","volume":"63","author":"Rucavado","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.tips.2021.02.005_bb0230","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.toxicon.2006.11.020","article-title":"Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators","volume":"49","author":"Howes","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.tips.2021.02.005_bb0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/toxins12010053","article-title":"Antivenom neutralization of coagulopathic snake venom toxins assessed by bioactivity profiling using nanofractionation analytics","volume":"12","author":"Xie","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008579","article-title":"An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management","volume":"14","author":"Ainsworth","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0245","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/toxins12090528","article-title":"Novel snakebite therapeutics must be tested in appropriate rescue models to robustly assess their preclinical efficacy","volume":"12","author":"Knudsen","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008727","article-title":"Interventions for the management of snakebite envenoming: an overview of systematic reviews","volume":"14","author":"Bhaumik","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0255","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/toxins9120382","article-title":"Multipurpose HTS coagulation analysis: assay development and assessment of coagulopathic snake venoms","volume":"9","author":"Still","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.toxicon.2020.05.022","article-title":"Development of high-throughput screening assays for profiling snake venom phospholipase A2 activity after chromatographic fractionation","volume":"184","author":"Still","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.tips.2021.02.005_bb0265","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/toxins11100600","article-title":"A taxon-specific and high-throughput method for measuring ligand binding to nicotinic acetylcholine receptors","volume":"11","author":"Zdenek","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bph.14081","article-title":"Inventing new therapies without reinventing the wheel: the power of drug repurposing","volume":"175","author":"Papapetropoulos","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2021.02.005_bb0275","doi-asserted-by":"crossref","first-page":"10750","DOI":"10.1073\/pnas.1810137115","article-title":"The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis","volume":"115","author":"Janes","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2021.02.005_bb0280","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","article-title":"Ultra-large library docking for discovering new chemotypes","volume":"566","author":"Lyu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.02.005_bb0285","doi-asserted-by":"crossref","first-page":"17203","DOI":"10.1038\/s41598-019-53755-5","article-title":"Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound varespladib (LY315920)","volume":"9","author":"Salvador","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.02.005_bb0290","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ccr3.3","article-title":"Reversal of experimental paralysis in a human by intranasal neostigmine aerosol suggests a novel approach to the early treatment of neurotoxic envenomation","volume":"1","author":"Lewin","year":"2013","journal-title":"Clin. Case Rep"},{"key":"10.1016\/j.tips.2021.02.005_bb0295","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/acs.jmedchem.0c01202","article-title":"Peptide inhibitors of the \u03b1-cobratoxin\u2013nicotinic acetylcholine receptor interaction","volume":"63","author":"Lynagh","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2021.02.005_bb0300","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fphar.2019.00848","article-title":"A decoy-receptor approach using nicotinic acetylcholine receptor mimics reveals their potential as novel therapeutics against neurotoxic snakebite","volume":"10","author":"Albulescu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2021.02.005_bb0305","doi-asserted-by":"crossref","first-page":"16727","DOI":"10.1038\/s41598-019-53216-z","article-title":"Investigation of protein-protein interactions and hot spot region between PD-1 and PD-L1 by fragment molecular orbital method","volume":"9","author":"Lim","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.02.005_bb0310","first-page":"55","article-title":"Technological and sociological advances in HTS: evolution and revolution?","volume":"18","author":"Clark","year":"2013","journal-title":"Eur. Pharm. Rev."},{"key":"10.1016\/j.tips.2021.02.005_bb0315","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1039\/c4md00011k","article-title":"The role of modern drug discovery in the fight against neglected and tropical diseases","volume":"5","author":"Burrows","year":"2014","journal-title":"Medchemcomm"},{"key":"10.1016\/j.tips.2021.02.005_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau2086","article-title":"Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis","volume":"11","author":"Taylor","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2021.02.005_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007159","article-title":"Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity","volume":"13","author":"von Geldern","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0330","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/inthealth\/ihx038","article-title":"For as long as necessary: examining 30 years of MSD\u2019s focus on achieving elimination of onchocerciasis and lymphatic filariasis","volume":"10","author":"Gustavsen","year":"2018","journal-title":"Int. Health"},{"key":"10.1016\/j.tips.2021.02.005_bb0335","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/avj.12993","article-title":"SnakeMap: four years of experience with a national small animal snake envenomation registry","volume":"98","author":"Boller","year":"2020","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.tips.2021.02.005_bb0340","article-title":"Snakebite and its impact in rural communities: the need for a One Health approach","volume":"13","author":"Martins","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0345","doi-asserted-by":"crossref","first-page":"109057","DOI":"10.1016\/j.vetpar.2020.109057","article-title":"Novel anti-Wolbachia drugs, a new approach in the treatment and prevention of veterinary filariasis?","volume":"279","author":"Turner","year":"2020","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.tips.2021.02.005_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008207","article-title":"Guinea worm in domestic dogs in Chad: a description and analysis of surveillance data","volume":"14","author":"Guagliardo","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006299","article-title":"Why snakebite patients in Myanmar seek traditional healers despite availability of biomedical care at hospitals? Community perspectives on reasons","volume":"12","author":"Schioldann","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004914","article-title":"The role of nurses and community health workers in confronting neglected tropical diseases in sub-Saharan Africa: a systematic review","volume":"10","author":"Corley","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0365","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/toxins9060187","article-title":"Coralsnake venomics: analyses of venom gland transcriptomes and proteomes of six Brazilian taxa","volume":"9","author":"Aird","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tips.2021.02.005_bb0370","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1038\/s41598-018-25955-y","article-title":"Venom proteomics and antivenom neutralization for the Chinese eastern Russell\u2019s viper, Daboia siamensis from Guangxi and Taiwan","volume":"8","author":"Tan","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.02.005_bb0375","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0140-6736(05)74319-1","article-title":"Crisis in snake antivenom supply for Africa","volume":"356","author":"Theakston","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.02.005_bb0380","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/525299a","article-title":"Africa braced for snakebite crisis","volume":"525","author":"Schiermeier","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.02.005_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008374","article-title":"Challenges and prospects of snake antivenom supply in sub-Saharan Africa","volume":"14","author":"Habib","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007551","article-title":"Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial","volume":"13","author":"Potet","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0395","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.trstmh.2007.11.006","article-title":"Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance","volume":"102","author":"Visser","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.tips.2021.02.005_bb0400","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.trstmh.2007.12.005","article-title":"Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product \u2013 \u2018What\u2019s in a name?","volume":"102","author":"Warrell","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.tips.2021.02.005_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003896","article-title":"Antivenoms for snakebite envenoming: what is in the research pipeline?","volume":"9","author":"Alirol","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2021.02.005_bb0410","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0031182013001108","article-title":"Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis","volume":"141","author":"Taylor","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.tips.2021.02.005_bb0415","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.02.005_bb0420","doi-asserted-by":"crossref","first-page":"i40","DOI":"10.1093\/inthealth\/ihx054","article-title":"Alternative treatment strategies to accelerate the elimination of onchocerciasis","volume":"10","author":"Boussinesq","year":"2018","journal-title":"Int. Health"},{"key":"10.1016\/j.tips.2021.02.005_bb0425","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1073\/pnas.1816585116","article-title":"AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis","volume":"116","author":"Hong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2021.02.005_bb0430","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aao1551","article-title":"Identification and prioritization of novel anti-Wolbachia chemotypes from screening a 10,000-compound diversity library","volume":"3","author":"Johnston","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2021.02.005_bb0435","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41467-018-07826-2","article-title":"Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides","volume":"10","author":"Clare","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721000432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721000432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:10:00Z","timestamp":1759050600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614721000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0165614721000432"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2021.02.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small Molecule Drug Discovery for Neglected Tropical Snakebite","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2021.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}